The leukocyte adhesion molecule L-selectin mediates neutrophil adhesive interactions with endothelial cells and is in part responsible for neutrophil rolling. We examined the role of L-selectin in ischemia-reperfusion injury of rabbit ears using a monoclonal antibody (MoAb) directed to a functional epitope of L-selectin. Arterial blood flow to the rabbit ear was occluded for six hours with ambient temperature at 23°C to 24°C. Rabbits were treated at reperfusion with saline (n = 81, the L-selectin function-blocking LAMI-3 MoAb (2 mg/kg), or the nonfunction-blocking LAMI-l4 MoAb (2 mg/ kg). Tissue injury was determined by measuring edema and SCHEMIA AND REPERFUSION cause significant tissue injury in a variety of clinical disorders, including stroke, myocardial infarction, organ transplantation, and organ hypoperfusion. Prolonged ischemia results in cellular necrosis, and only prompt restoration of blood flow will prevent this type of injury. However, reperfusion itself can cause significant injury of previously ischemic t i~s u e . "~ Reperfusion injury has been associated with activation of the inflammatory system and enhanced leukocyte-endothelial cell (EC) adhesion.' Stimulated polymorphonuclear leukocytes (PMNs) cause injury to ECs in vitro,'-'' and close contact or PMN-EC adhesion is required for injury to o~c u r .~.~. "
necrosis. Edema in the LAMI-3 MoAb-treated group (peak
= 25 f 4 mL) was significantly less ( P < .05) than in salinetreated (peak = 40 f 8 mL) and LAMI-l4 MoAb-treated (peak = 41 ? 6 mL) groups. Tissue necrosis at 7 days was not observed in the LAMI-3 MoAb-treated group, whereas significant necrosis (P < .05) was seen in the saline-(8% k 3% necrosis) and LAMI-l4 MoAb-treated (7% ? 396 necrosis) group. We conclude that blocking L-selectin ameliorates necrosis and edema after ischemia and reperfusion in the rabbit ear, presumably by blocking neutrophil rolling.
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sors, and immature thymocytes.".*" L-selectin supports adhesion of lymphocytes to high endothelial venules of peripheral lymph node^,'^.*'"^ and neutrophil adhesion to cytokine-stimulated monolayers of human umbilical vein ECs under nonstatic conditions in vitro 19~20.2'-27 and in
Mouse neutrophils treated with the MEL-14 monoclonal antibody (MoAb) (reactive with mouse L-selectin) ex vivo, or activated with agents that induce loss of Lselectin, have a decreased ability to home to inflamed tissues in vivo,"'." The MEL-14 MoAb blocks neutrophil interactions with high endothelial venules in vitro,"' and the intravenous administration of MEL-14 antibody or recombinant mouse L-selectin suppresses neutrophil accumulation within the inflamed peritoneum.'"" Finally, mouse neutrophils activated in vitro with agents that induce loss of L-selectin have a decreased ability to home to inflamed t i~s u e s .~' These findings all confirm that members of the selectin family of adhesion receptors, including L-selectin, mediate the initial interactions between leukocytes and ECs, which precede firm adhesion mediated by members of the integrin family.'7.'s Blocking neutrophil adherence and/or aggregation with MoAbs to CD1 1/CD18'4-'9 and P-selectin4. 4 (1 have been shown to ameliorate reperfusion injury. In the experiments described here, we examined the effect of MoAbs directed to functional epitopes of L-selectin on the development of reperfusion injury in the rabbit ear.
vivo, 16.17.28.19 
MATERIALS AND METHODS
MoAbs. The LAMI -3 and LAMI-l4 MoAbs are murine IgG, antibodies to human L-selectin." The LAMI-3 and LAMI-l4 MoAbs were produced as ascites fluid in mice and LAMI-3 was also produced as pure MoAb by batch fermentation. Mouse ascites fluid was salt fractionated and the MoAb purified by diethyl aminoethyl ion-exchange chromatography using endotoxin-free reagents. The LAMI-3 MoAb produced by batch fermentation was isolated by affinity chromatography using protein A. F(ab'), fragments of the LAMI-3 MoAb were produced as described4' then purified by anion-exchange chromatography. MoAb and F(ab'L fragments were concentrated, transferred into sterile saline by ultrafiltration (Amicon Corp, Danvers, MA), and quantitated by light absorbance. The purity of the MoAb and MoAb fragments was verified by gel electrophoresis on a sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel (12%) under reducing and nonreducing conditions. Purified MoAb preparations contained no detectable endotoxin contamination as assessed by monitoring the gelation of limulus amoebocyte lysate. For personal use only. on October 26, 2017 . by guest www.bloodjournal.org From either L-selectin MoAb or saline, and animals having ears subjected to ischemia reperfusion. Samples were taken before and at 1,4, and 24 hours after MoAb administration in normal animals. The ischemia-reperfusion animals had samples taken at baseline and at 0.5, I , 2, 4, and 24 hours after reperfusion. Cells were processed as described below for determination of L-selectin expression using an indirect staining technique. The degree of saturation of circulating leukocytes with LAMl-3 MoAb after its intravenous administration was determined from the intensity of fluorescence staining. The withdrawn cells were labeled in vitro with the fluorescein isothiocyanate (FITC)-conjugated secondary antibody alone, and were compared with those given additional LAMI-3 MoAb in vitro before secondary antibody; ie, the secondary MoAb will detect any murine MoAb present on the circulating cells and if they are saturated, the addition of more MoAb will not change the histogram.
Fluorescence-activated cell sorting (FACS
Whole blood samples (collected in heparin) were immediately cooled and prepared throughout at 4°C. Erythrocytes in the whole blood were lysed in NH,CIIKHCOJtetrasodium EDTA solution and leukocytes (white blood cells; WBCs) isolated by centrifugation. The WBC pellet was washed in phosphate-buffered saline (PBS) (divalent cation-free) followed by trypan blue exclusion to confirm WBC viability greater than 95%. After incubation with heat-inactivated bovine serum, WBCs were incubated with additional LAM1-3 MoAb and/or FITC-conjugated goat-antimouse IgG antibody as a secondary reagent. After a final wash, the WBCs were fixed in 1% paraformaldehyde and stored at 4°C in the dark. Granulocytes and monocytes were separated from other WBCs by appropriate gating of cell size and granularity on the basis of characteristic forward and perpendicular light-scatter observations. Histograms of cell number versus fluorescence intensity were generated using at least 5,000 cells per sample.
Animals, surgical preparation, and protocol. New Zealand White rabbits (=2 kg body weight) were used in all experiments. The protocols were reviewed and approved by the University of Washington Animal Care Committee. Experiments were performed in accordance with the National Institutes of Health guidelines for the care and use of experimental animals. A peripheral ear vein was cannulated and the rabbit anesthetized with intravenous ketamine and xylazine. Local nerve block was accomplished by injection of lidocaine at the base of the ear. This ear was then transected at its base, leaving intact only the central artery, central vein and a small portion of supporting cartilage. All nerves to the distal segment of the ear were cut, rendering the ear completely anesthetic. A microvascular clip was placed on the central artery of the left ear to produce complete ischemia. The ear was then reattached with suture and the microvascular clip allowed to exit through the wound. Reperfusion of the ear was accomplished by removing the clip at 6 hours. The ambient temperature was maintained between 23.5"C and 24°C throughout the experiment.
Rabbits were treated with either saline, the L-selectin blocking LAMI-3 MoAb, or the nonblocking L-selectin LAMI-l4 MoAb at the time of reperfusion. Both MoAbs were given by bolus intravenous injection at a dose of 2 mgkg. The saline-treated animals received a volume of saline equal to that given the MoAb-treated animals. The investigator in charge of measurements and care of the animals was unaware of the treatment. All animals were returned to the their cages after surgery and had free access to food and water.
Measurement of injury, Ear edema and tissue necrosis were measured as previously de~cribed.'~ Briefly, tissue edema was measured as the volume determined by submerging the ear into a beaker of water up to the suture line then measuring the amount of water that was displaced. Ear volume was measured daily for seven days. These measurement were repeatable to within 1 to 2 mL. Tissue necrosis (estimated by simple observation of the ear as a percentage of total surface area) was determined by a single unbiased observer with the estimate being made on day 7.
Myeloperoxidase (MPO) assay. MP0 is found in the granules of neutrophils and has been used as an indicator of PMN emigration into
The previously described photometric technique to determine MP0 concentration was
The skin from the ears of rabbits was removed from the cartilage of normal rabbit ears and from ears subjected to ischemia and allowed to reperfuse for =24 hours. The tissue was weighed and then homogenized in PBS containing 0.5% hexadecyltrimethylammonium bromide (HTAB). Five hundred milligrams of tissue was added to 1 mL of the PBSEITAB solution for homogenization. After homogenization, these solutions were freeze-thawed three times and sonicated twice to disrupt the cells. The mixture was then centrifuged at l0,OaOg for 10 minutes. The supernatant fluid was decanted and heated at 60°C for 120 minutes to inactivate inhibitors of MP0
Optical density was measured at 460 nm and is to be directly proportional to MP0 c~ncentration!~ Thus, total MP0 in the tissue that was homogenized is proportional to the sample optical density multiplied by the volume of the homogenate (assuming the sample representative of the ear). PMN infiltration was assumed proportional to total MP0 content.
Circulating PMNs. Blood samples were taken from normal rabbits before administration of both LAMl-3 and LAMl-14 MoAb and at 15, 30, 60, and 240 minutes after the intravenous injection of MoAbs. These rabbits were not subjected to any additional experimental protocol during this 4-hour period. Blood smears were made on microscope slides and stained with Wright-Giemsa. Total WBC counts were completed using a hemocytometer and differential cell counts from the stained slides. Total PMN counts were determined from these results.
Statistics. Ear volumes for the 7-day study and PMN counts for 4 hours after MoAb injection were compared for statistical significance by analysis of variance (ANOVA) for repeated measures. When this analysis indicated significant differences, a post hoc test was completed using Fisher's protected least significant difference test. Tissue necrosis on day 7 and MP0 activity were compared by analysis of variance (ANOVA) and post hoc testing with Fisher's PLSD test. Data given in text and figures are means 2 SE. Results were considered statistically significant for P < .05. All of the analyses were completed using the computer program StatView 4.0 (Abacus Concepts, Berkeley, CA).
RESULTS

Expression of L-selectin. The LAMI-3 and LAMI-14
MoAbs recognize a molecule (probably L-selectin, see Discussion) on rabbit PMNs as shown by the fluorescence histograms of Fig 1. The histogram curves to the left in Fig 1, A and B are the fluorescence profiles from blood cells drawn before MoAb-treatment and the histograms to the right were from blood drawn at 4 hours. In each case, cells were treated in vitro with labeled secondary goat-antimurine IgG antibody. The histograms generated after either LAMI-3 or LAMI-l4 MoAb treatment clearly show that both of these MoAbs recognize rabbit PMNs to a similar extent.
The fluorescence intensity of cells drawn at 4 and 24 hours and treated with labeled secondary antibody were compared with the fluorescence intensity of cells treated with additional LAMl-3 MoAb in vitro. The histograms were similar regardless of whether additional MoAb was given. Also, the fluorescence histogram from blood drawn before MoAb-treatment and labeled with both primary and secondary antibodies in vitro showed no signs of L-selectin shedding and there were no differences between MoAb LAMl-3 and there was a significant ( P < .05) reduction in total circulating PMN counts in blood from each of the groups of animals (Fig 2) . Differences between groups were not significant. PMN counts decreased to ~3 5 % of baseline in each group after antibody administration and this decrease was observed as early as 10 minutes after injecting the MoAb and persisted for up to 60 minutes. By 7 hours after MoAb injection, a neutrophila was seen in five animals (not shown in Fig 2) . The MoAb LAM1-3-treated animals had an average of 3,600 cells/mL and the MoAb LAMI-14-treated animals averaged 3,000 cells/mL. Because the differences between groups were not statistically significant and gel electrophoresis of the LAMI-3 MoAb F(ab'), fragment preparation failed to detect intact Ig or Fc fragments, it is unlikely that Fc receptors were responsible for the observed neutropenia. Contaminants of the MoAb preparations did not contribute to neutropenia because intraperitoneal injection of 0.5 mg of each MoAb preparation into Balb/c mice failed to induce any demonstrable neutropenia in comparison with saline injections (data not shown). Thus, it is possible that crosslinking of leukocyte cell surface L-selectin activates the leukocyte and results in alterations in the properties of the PMNs.
ESfect of blocking L-selectin function on reperfusion injury. Ears from three groups of rabbits, eight animals in each group, were subjected to ischemia and reperfusion. The average initial ear volume in all three groups was almost identical at =7.5 mL. Tissue edema occurred early after reperfusion and persisted to varying degrees for the entire 7-day period of study (Fig 3) . The saline and LAM1-14 MoAb-treated animals had the most severe tissue edema, with an average ear volume at 24 hours of 27 % 6 mL and 29 2 4 m L , respectively. The peak increase in ear volume occurred on day 3 and averaged 40 2 8 mL and 41 2 6 mL for saline and LAM1-14 MoAb-treated rabbits, respectively. Rabbits treated with LAM1-3 MoAb at the time of reperfusion had an average ear volume of 17 4 mL at 24 hours that peaked at 25 4 mL on day 5 . There were no differences For personal use only. on October 26, 2017. by guest www.bloodjournal.org From Tissue necrosis observed at the end of the experiment was used as a supplemental estimate for damage to the rabbit ear tissue. Necrosis was significantly less in LAMI-3 MoAbtreated animals compared with saline and LAMI-l4 MoAbtreated animals (Fig 4) . Tissue loss was estimated at 8% C 3% for the saline-treated group and 7% 5 3% for LAMI-14 MoAb-treated group, compared with the absence of any observed necrosis in the LAMI-3 MoAb-treated group.
These differences were statistically significant ( P < .OS). For protection afforded by the administration of LAM1-3 MoAb resulted from a reduced accumulation of PMNs after ischemia and reperfusion.
DISCUSSION
Tissue injury resulting from ischemia and reperfusion contributes to several important clinical disorders including myocardial infarction, stroke, and circulatory shock. In this study, L-selectin was shown to play a major role during ischemia-reperfusion injury in the rabbit ear. Blocking of Lselectin function using the LAMl-3 MoAb eliminated most of the tissue edema and necrosis that followed ischemia ( Figs  3 and 4) . This protective effect was mediated by blocking L-selectin function directly because treating rabbits with the LAMl-I4 MoAb, an antibody that does not block L-selectin function, had no protective effect and yielded results equivalent to the administration of saline. The presumed action of the LAM1-3 MoAb is through the inhibition of leukocyte rolling along the EC surface. This MoAb has been shown previously to block leukocyte rolling in vivo?' Blocking leukocyte rolling prevents the subsequent firm adherence of neutrophils to the e n d o t h e l i~m~~.~~ thereby resulting in significant protection of the rabbit ear as measured by tissue edema and tissue necrosis. Therefore, our results are consistent with the hypothesis that neutrophil emigration into inflamed tissue makes use of the L-selectin adhesion receptor.
The LAM 1-3 and LAM l -14 MoAb clearly identified Lselectin in the rabbit for the following reasons. First, the Lselectin structure is well conserved between rabbit and man because nine of fourteen MoAbs that identify distinct epitopes on the human protein are also expressed by rabbit leukocytes!' Therefore, it is unlikely that all of these MoAbs identify a molecule other than the authentic rabbit L-selectin molecule. Furthermore, L-selectin is rapidly shed from the cell surface after leukocyte activation and all of the previously listed nine MoAbs fail to react with activated rabbit leukocytes (data not shown). Also, seventeen human L-selectin-directed MoAbs have been used to examine rabbit thymus lymph nodes and appendix with immunohistochemical analysis without any observed reactivity other than leukoc y t e~.~' Although one MoAb has been described that reacts with both human L-and E-~electin,~' the LAM 1-3 and LAMI-14 MoAbs do not bind to human, mouse, or bovine E-or P-selectin. Therefore, it is unlikely that these MoAbs identify molecules other than L-selectin expressed by leukocytes. The functional significance of the LAMl-3 MoAb is likely caused by direct blockade of ligand binding in the rabbit because the LAML-3 MoAb blocks rabbit leukocyte binding of phosphomannan monoester (PPME), a core pdysaccharide that serves as a soluble model of the natural ligand of L-~electin.~' Similarly, the LAMI-3 MoAb also blocks L-selectin function in humans, rhesus monkeys, cows, and dogs as assessed by inhibition of PPME binding and lymphocyte attachment to peripheral lymph node high endothel i~m .~' In all of these in vitro experimental settings, maximal blocking of L-selectin function was obtained using MoAb concentrations of 5 to 10 ,ug/mL. Because the LAMI -14 MoAb binds to an epitope in the short consensus repeat domains of human L-selectin, and this MoAb has never been observed to block function in any animal, it is likely that has functional effects in rabbits.
Similar experiments by Vedder et al" have shown that leukocyte-mediated ischemia reperfusion injury in the rabbit ear can be significantly attenuated by treatment with a CD 18 MoAb. In those studies, an MoAb reactive with CD18 markedly attenuated edema formation and tissue necrosis produced by 10 hours of ischemia followed by reperfusion. Importantly, protection was as effective when the MoAb was administered before ischemia as it was when given just before reperfusion and there was no statistical difference between animals subjected to the operation alone (no ischemia) For personal use only. on October 26, 2017 . by guest www.bloodjournal.org From and the ischemia-reperfusion group treated with MoAb. The level of protection provided by the L-selectin-directed MoAb in this study was similar to the results obtained with the CD18 MoAb. These results suggest that leukocyte-mediated damage in reperfusion injury can be significantly attenuated by either blocking leukocyte rolling with an L-selectindirected MoAb or by blocking firm adhesion using a CD18 MoAb, with similar outcomes.
Treatment of rabbits with a P-selectin-directed MoAb PB 1.3 was effective in preventing tissue edema in an experimental protocol identical to the one used in the present study: In those experiments, rabbit ears were made ischemic for 6 hours at 23°C to 24°C before reperfusion was initiated. The equal protective effect of L-and P-selectin-directed MoAbs suggests that these receptors may cooperate to mediate different phases of leukocyte rolling. Although it has been suggested that L-and P-selectin form a receptor-ligand pair with P-selectin binding to SLe" on L -s e l e~t i n ,~~ L-selectin can also mediate leukocyte rolling in vivo independent of E-or P-selectin." Therefore, L-and P-selectin are likely to function sequentially in mediating initial leukocyte interactions with ECs. After endothelial activation in vitro, Pselectin is expressed rapidly:' while the ligand for L-selectin is induced at later time points and persists for up to 72 hours.25 Alternatively, the interactions between pairs of selectins and their ligands will be required for efficient leukocyte rolling. Although this would suggest that therapeutic agents that inhibit the function of multiple selectins may be advantageous, the effects observed in this model of reperfusion injury clearly suggest that disrupting a single selectin can have dramatic therapeutic effects.
The mechanism leading to neutropenia after injection of MoAb directed toward L-selectin is unknown (Fig 2) . F(ab'), fragments of LAMl-3 MoAb also caused equivalent neutropenia compared with intact MoAb, thus, it is unlikely that the MoAb caused margination of leukocytes as a result of Fc receptor interactions or complement activation. Both the function-blocking LAM 1-3 MoAb and the nonfunctionblocking LAM1-14 MoAb caused a similar reduction in circulating PMN numbers. However, only the adhesion blocking LAM1-3 MoAb reduced vascular and tissue injury after ischemia and reperfusion. Therefore, the protective effects of the LAMI-3 MoAb can not be attributed to neutropenia alone and protection is consistent with their blocking the ligand-binding activity of L-selectin.
We conclude that L-selectin facilitates leukocyte interactions with endothelium after ischemia and reperfusion. Blocking L-selectin function at the time of reperfusion prevents much of the injury associated with ischemia-reperfusion under these conditions. Because the therapeutic effectiveness of L-selectin MoAb was comparable with that previously reported for CD18 MoAb, this suggests that blocking either leukocyte rolling or firm adhesion can prevent reperfusion injury. The significant protective effects of MoAb in this ischemia-reperfusion model of injury provides further evidence that selectin-dependent adhesive interactions between leukocytes and ECs may be appropriate targets for anti-inflammatory interventions applicable to other syndromes.
